Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Thompson

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Scientific Reports|March 16, 2022
A national survey of physical activity after spinal cord injuryJan Elaine Soriano, Jordan W Squair, Jacquelyn J Cragg, et al.
The Lancet. Microbe|December 13, 2025
Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trialGiorgia Gon, Sokvy Ma, Alexander M Aiken, et al.
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
American Journal of Clinical Oncology|June 21, 2016
Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of PredictorsSusan B Kesmodel, Olga G Goloubeva, Paula Y Rosenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
The Lancet. Global Health|April 15, 2023
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trialXiaoqiu Liu, Jennifer Thompson, Haiyan Dong, et al.
The Lancet. Infectious Diseases|November 8, 2017
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialJames G Hakim, Jennifer Thompson, Cissy Kityo, et al.
Environment International|January 21, 2019
Prenatal particulate air pollution exposure and sleep disruption in preschoolers: Windows of susceptibilitySonali Bose, Kristie R Ross, Maria J Rosa, et al.
Acta Neuropathologica|October 14, 2005
Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlationJing Shi, Catherine L Shaw, Daniel Du Plessis, et al.
American Journal of Obstetrics and Gynecology|February 5, 2022
Gynecologic surgical skill acquisition through simulation with outcomes at the time of surgery: a systematic review and meta-analysisFrancisco J Orejuela, Sarit O Aschkenazi, David L Howard, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Scientific Reports|March 16, 2022
A national survey of physical activity after spinal cord injuryJan Elaine Soriano, Jordan W Squair, Jacquelyn J Cragg, et al.
The Lancet. Microbe|December 13, 2025
Impact of a multicomponent training intervention (Clean FrontLine) on microbiological cleanliness in Cambodian referral hospitals: a multicentre, stepped-wedge, cluster-randomised trialGiorgia Gon, Sokvy Ma, Alexander M Aiken, et al.
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
American Journal of Clinical Oncology|June 21, 2016
Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of PredictorsSusan B Kesmodel, Olga G Goloubeva, Paula Y Rosenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 28, 2017
HIV Drug Resistance Mutations in Non-B Subtypes After Prolonged Virological Failure on NNRTI-Based First-Line Regimens in Sub-Saharan AfricaCissy Kityo, Jennifer Thompson, Immaculate Nankya, et al.
The Lancet. Global Health|April 15, 2023
Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trialXiaoqiu Liu, Jennifer Thompson, Haiyan Dong, et al.
The Lancet. Infectious Diseases|November 8, 2017
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialJames G Hakim, Jennifer Thompson, Cissy Kityo, et al.
Environment International|January 21, 2019
Prenatal particulate air pollution exposure and sleep disruption in preschoolers: Windows of susceptibilitySonali Bose, Kristie R Ross, Maria J Rosa, et al.
Acta Neuropathologica|October 14, 2005
Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlationJing Shi, Catherine L Shaw, Daniel Du Plessis, et al.
American Journal of Obstetrics and Gynecology|February 5, 2022
Gynecologic surgical skill acquisition through simulation with outcomes at the time of surgery: a systematic review and meta-analysisFrancisco J Orejuela, Sarit O Aschkenazi, David L Howard, et al.
Pageof 18